Central African Republic vs Yemen: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Central African Republic
42.0%
in 2024
Yemen
41.0%
in 2024
Central African Republic rank
141st
Yemen rank
142nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Central African Republic
- Yemen
How they compare
Central African Republic currently reports 42.0% against 41.0% in Yemen, a difference of 1.0%.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Yemen ahead.
Central African Republic ranks 141st and Yemen ranks 142nd of 146 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.3% | 60.0% | 23.7% | Yemen |
| 2020s | 36.6% | 50.6% | 14.0% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Central African Republic or Yemen?
- Central African Republic, at 42.0% against 41.0% in Yemen as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Central African Republic and Yemen?
- 1.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Yemen?
- 14 years are reported by both, from 2011 to 2024.
- How do Central African Republic and Yemen rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Central African Republic ranks 141st and Yemen ranks 142nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.